AB126
Acute neuro-conditions and chronic neurodegenerative diseases
Pre-clinicalActive
Key Facts
Indication
Acute neuro-conditions and chronic neurodegenerative diseases
Phase
Pre-clinical
Status
Active
Company
About Aruna Bio
Aruna Bio, founded in 2016 and based in Athens, Georgia, is a private, preclinical-stage biotech focused on harnessing neural exosomes for central nervous system (CNS) disorders. The company's platform aims to overcome the significant challenge of blood-brain barrier penetration, with its lead program, AB126, demonstrating anti-inflammatory, neuroprotective, and pro-regenerative properties. With an experienced board and leadership team, Aruna Bio is building a pipeline targeting both acute and chronic neurodegenerative conditions, positioning itself in a high-need, high-value therapeutic area.
View full company profile